Jakavi 15 mg tablets, Jakavi 5 mg tablets, Jakavi 10 mg tablets, Jakavi 20 mg tablets
Phase 2 small_molecule active
Quick answer
Jakavi 15 mg tablets, Jakavi 5 mg tablets, Jakavi 10 mg tablets, Jakavi 20 mg tablets for haemophagocytic lymphohistiocytosis (HLH) in children is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- haemophagocytic lymphohistiocytosis (HLH) in children
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active